Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$13.02 - $22.62 $2,786 - $4,840
214 Added 1.0%
21,704 $295,000
Q4 2022

Jan 24, 2023

SELL
$17.77 - $21.6 $103,385 - $125,668
-5,818 Reduced 21.31%
21,490 $0
Q3 2022

Oct 25, 2022

SELL
$18.6 - $27.25 $2,920 - $4,278
-157 Reduced 0.57%
27,308 $520,000
Q2 2022

Jul 21, 2022

BUY
$16.57 - $35.1 $455,095 - $964,021
27,465 New
27,465 $566,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.